PDEX · Company research
Pro-Dex Inc New (PDEX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (PDEX) Movement as an Input in Quant Signal Sets - Stock Traders Daily | (PDEX) Movement as an Input in Quant Signal Sets Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 13, 2026 | neutral | 0 | 0.6 |
| Repair revenue fell 33%, but fiscal 2026 profit rose at Pro-Dex (PDEX). - Stock Titan | Repair revenue fell 33%, but fiscal 2026 profit rose at Pro-Dex (PDEX). Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| (PDEX) Volatility Zones as Tactical Triggers - Stock Traders Daily | (PDEX) Volatility Zones as Tactical Triggers Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 3, 2026 | neutral | 0 | 0.6 |
| PDEX Q3 2026 Earnings: EPS Beats Estimate by 27.3% Despite Modest Stock Decline - Share Repurchase Impact - https://www.dars.gov.et/ | PDEX Q3 2026 Earnings: EPS Beats Estimate by 27.3% Despite Modest Stock Decline - Share Repurchase Impact https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 3, 2026 | neutral | 0 | 0.6 |
| Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex | The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 0.8 | 1 |
| Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex | The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 0.8 | 1 |
| 5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve | The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets. | View source ↗ | Zacks Investment Research | Oct 1, 2026 | bullish | 0.6 | 1 |
| 5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve | The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets. | View source ↗ | Zacks Investment Research | Oct 1, 2026 | bullish | 0.6 | 1 |
| How Pro-dex Inc. (PDEX) Affects Rotational Strategy Timing - Stock Traders Daily | How Pro-dex Inc. (PDEX) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 23, 2026 | neutral | 0 | 0.6 |
| Pro Dex CEO Richard Van Kirk sells $45,412 in PDEX stock - Investing.com UK | Pro Dex CEO Richard Van Kirk sells $45,412 in PDEX stock Investing.com UK | View source ↗ | Investing.com UK | Sep 15, 2026 | neutral | 0 | 0.6 |
| Pro-Dex (PDEX) CFO sells shares without a preset trading plan - Stock Titan | Pro-Dex (PDEX) CFO sells shares without a preset trading plan Stock Titan | View source ↗ | Stock Titan | Sep 10, 2026 | neutral | 0 | 0.6 |
| Share sale notice at Pro-Dex (NASDAQ: PDEX) leaves one key number for investors to check - Stock Titan | Share sale notice at Pro-Dex (NASDAQ: PDEX) leaves one key number for investors to check Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| Pro-Dex (PDEX) Stock Rally Masks One Off Boost To Earnings - Simply Wall Street | Pro-Dex (PDEX) Stock Rally Masks One Off Boost To Earnings Simply Wall Street | View source ↗ | Simply Wall Street | Sep 5, 2026 | neutral | 0 | 0.6 |
| $PDEX stock is up 19% today. Here's what we see in our data. - Quiver Quantitative | $PDEX stock is up 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 4, 2026 | neutral | 0 | 0.6 |
| Pro-Dex Posts $20.4 Million Q4 Sales and $2.9 Million Net Income - Quiver Quantitative | Pro-Dex Posts $20.4 Million Q4 Sales and $2.9 Million Net Income Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 3, 2026 | neutral | 0 | 0.6 |
| Pro-Dex Inc. (PDEX) Retreats from Recent Highs, Testing Key Support Levels - PCR Mean Reversion - dars.gov.et | Pro-Dex Inc. (PDEX) Retreats from Recent Highs, Testing Key Support Levels - PCR Mean Reversion dars.gov.et | View source ↗ | dars.gov.et | Jul 19, 2026 | neutral | 0 | 0.6 |
| Pro-Dex: Still A Buy, But Don’t Chase (NASDAQ:PDEX) - Seeking Alpha | Pro-Dex: Still A Buy, But Don’t Chase (NASDAQ:PDEX) Seeking Alpha | View source ↗ | Seeking Alpha | May 15, 2026 | neutral | 0 | 0.6 |
| Pro-Dex Completes Acquisition of Advanced Precision Machining - The Globe and Mail | Pro-Dex Completes Acquisition of Advanced Precision Machining The Globe and Mail | View source ↗ | The Globe and Mail | Feb 13, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 14, 2024 | neutral | 0 | 0.6 |
| Pro-Dex, Inc. (PDEX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Pro-Dex, Inc. (PDEX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | May 23, 2017 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.